Trials / Completed
CompletedNCT03015454
An Algorithm Driven Sepsis Prediction Biomarker
A Randomized Controlled Clinical Trial of an Algorithm Driven Sepsis Prediction Biomarker
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- Dascena · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A sepsis early warning predictive algorithm, InSight, has been developed and validated on a large, diverse patient cohort. In this prospective study, the ability of InSight to predict severe sepsis patients is investigated. Specifically, InSight is compared with a well established severe sepsis detector in the UCSF electronic health record (EHR).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Severe Sepsis Prediction | Upon receiving an InSight alert, healthcare provider follows standard practices in assessing possible (severe) sepsis and intervening accordingly. |
| OTHER | Severe Sepsis Detection | Upon receiving information from the severe sepsis detector in the UCSF electronic health record, healthcare provider follows standard practices in assessing possible (severe) sepsis and intervening accordingly. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2017-02-01
- First posted
- 2017-01-10
- Last updated
- 2021-09-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03015454. Inclusion in this directory is not an endorsement.